Skip to content

In the BioHarmony Drug Report Database

Histamine dihydrochloride

Ceplene (histamine dihydrochloride) is a small molecule pharmaceutical. Histamine dihydrochloride was first approved as Ceplene on 2008-10-07. It is used to treat allergic rhinitis seasonal and urticaria in the USA. It has been approved in Europe to treat myeloid leukemia acute.
Trade Name Ceplene
Common Name Histamine dihydrochloride
Indication allergic rhinitis seasonal, myeloid leukemia acute, urticaria
Drug Class
Histamine dihydrochloride
Get full access now